Genmab A/S

Genmab A/Sverified

GNMSF

Price:

$214.95

Market Cap:

$83.71B

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating sol...[Read more]

Industry

Biotechnology

IPO Date

2010-01-05

Stock Exchange

OTC

Ticker

GNMSF

The Current Ratio as of July 2025 (TTM) for Genmab A/S (GNMSF) is 5.34

According to Genmab A/S’s latest financial reports and current stock price. The company's current Current Ratio is 5.34. This represents a change of 2.77% compared to the average of 5.20 of the last 4 quarters.

Genmab A/S (GNMSF) Historical Current Ratio (quarterly & annually)

How has GNMSF Current Ratio performed in the past?

The mean historical Current Ratio of Genmab A/S over the last ten years is 13.46. The current 5.34 Current Ratio has changed 3.87% with respect to the historical average. Over the past ten years (40 quarters), GNMSF's Current Ratio was at its highest in in the March 2018 quarter at 23.99. The Current Ratio was at its lowest in in the June 2024 quarter at 5.03.

Quarterly (TTM)
Annual

Average

13.46

Median

14.69

Minimum

5.25

Maximum

18.52

Genmab A/S (GNMSF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genmab A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 109.88%

Maximum Annual Current Ratio = 18.52

Minimum Annual Increase = -60.67%

Minimum Annual Current Ratio = 5.25

Quarterly (TTM)
Annual
YearCurrent RatioChange
20245.25-60.67%
202313.34-14.29%
202215.577.35%
202114.50-3.31%
202015.000.76%
201914.88-11.22%
201816.77-9.49%
201718.5255.65%
201611.9034.45%
20158.85109.88%

Genmab A/S (GNMSF) Average Current Ratio

How has GNMSF Current Ratio performed in the past?

The current Current Ratio of Genmab A/S (GNMSF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

11.38

5-year avg

12.73

10-year avg

13.46

Genmab A/S (GNMSF) Current Ratio vs. Peers

How is GNMSF’s Current Ratio compared to its peers?

Genmab A/S’s Current Ratio is less than Microbix Biosystems Inc. (9.36), less than Genmab A/S (5.34), less than Inhibikase Therapeutics, Inc. (11.01), greater than Purple Biotech Ltd. (2.23), greater than CSL Limited (1.86), greater than Ucb S.A. (1.36), greater than CSL Limited (1.86), greater than Novo Nordisk A/S (0.74), greater than Sino Biopharmaceutical Limited (1.26),

Build a custom stock screener for Genmab A/S (GNMSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genmab A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genmab A/S (GNMSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genmab A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Genmab A/S's Current Ratio?

How is the Current Ratio calculated for Genmab A/S (GNMSF)?

What is the highest Current Ratio for Genmab A/S (GNMSF)?

What is the 3-year average Current Ratio for Genmab A/S (GNMSF)?

What is the 5-year average Current Ratio for Genmab A/S (GNMSF)?

How does the current Current Ratio for Genmab A/S (GNMSF) compare to its historical average?